Fetal Mesenchymal Stem-Cell Engraftment in Bone after In Utero Transplantation in a Patient with Severe Osteogenesis Imperfecta-Reference-Cited by-同舟云学术

Fetal Mesenchymal Stem-Cell Engraftment in Bone after In Utero Transplantation in a Patient with Severe Osteogenesis Imperfecta

Published:2005-06-15 Issue:11 Volume:79 Page:1607-1614
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Le Blanc Katarina,Götherström Cecilia,Ringdén Olle,Hassan Moustapha,McMahon Robert,Horwitz Edwin,Anneren Göran,Axelsson Ove,Nunn Janice,Ewald Uwe,Nordén-Lindeberg Solveig,Jansson Monika,Dalton Ann,Åström Eva,Westgren Magnus

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference47 articles.

1. Engraftment and long-term expression of human fetal hemopoietic stem cells in sheep following transplantation in utero.;Zanjani;J Clin Invest,1992

2. Transplantation of hemopoietic cells from the fetal liver to treat patients with congenital diseases postnatally or prenatally.;Touraine;Transplant Proc,1997

3. In utero hematopoietic stem cell transplantation: Ontogenic opportunities and biologic barriers.;Flake;Blood,1999

4. Lack of evidence of permanent engraftment after in utero fetal stem cell transplantation in congenital hemoglobinopathies.;Westgren;Transplantation,1996

5. Fetal hematopoietic stem cell transplantation: A challenge for the twenty-first century.;Shields;J Hematother Stem Cell Res,2002

Cited by 385 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fetal Therapies – (stem cell transplantation; enzyme replacement therapy; in utero genetic therapies);Best Practice & Research Clinical Obstetrics & Gynaecology;2024-09

2. Stem Cells in Bone Tissue Engineering: Progress, Promises and Challenges;Stem Cell Reviews and Reports;2024-07-19

3. Successful transport across continents of GMP-manufactured and cryopreserved culture-expanded human fetal liver-derived mesenchymal stem cells for use in a clinical trial;Regenerative Therapy;2024-06

4. An exploratory open-label multicentre phase I/II trial evaluating the safety and efficacy of postnatal or prenatal and postnatal administration of allogeneic expanded fetal mesenchymal stem cells for the treatment of severe osteogenesis imperfecta in infants and fetuses: the BOOSTB4 trial protocol;BMJ Open;2024-06

5. New Perspectives of Therapies in Osteogenesis Imperfecta—A Literature Review;Journal of Clinical Medicine;2024-02-13